Mycophenolate mofetil in the therapy of severe myasthenia gravis

European Neurology

Volumn 46, Issue 2, 2001, Pages 79-82

  Schneider, C ^a   Gold, R ^a   Reiners, K ^a   Toyka, K V ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Myasthenia gravis, therapy; Mycophenolate mofetil; Polymyositis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AGED; ARTICLE; CASE REPORT; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEMOLYTIC ANEMIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ANEMIA, HEMOLYTIC; AUTOANTIBODIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; MYCOPHENOLIC ACID; NEUROLOGIC EXAMINATION; RECEPTORS, CHOLINERGIC; TREATMENT OUTCOME;

EID: 0034860169     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050768     Document Type: Article

References (21)

1. Myasthenia gravis: Study of humoral immune mechanisms by passive transfer to mice
2. Therapy for myasthenia gravis and myasthenic syndromes
3. Newer immunosuppressive drugs: A review
4. Clear benefit of mycophenolate mofetil-based triplet therapy in reducing the incidence after living donor renal transplantation
5. Treatment of rheumatoid arthritis with mycophenolate mofetil
6. Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis. A pilot study in 11 patients with renal involvement
7. Treatment of pemphigus vulgaris with mycophenolate mofetil
8. Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy, and safety
9. Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease
10. Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease
11. Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil
12. Mycophenolate mofetil - A safe and promising immunosup-pressant in neuromuscular diseases
13. Preliminary results of an open label trial of Cellcept in myasthenia gravis
14. Mycophenolate mofetil is safe and well-tolerated in myasthenia gravis
15. The efficacy of the combination of tacrolimus and mycophenolate mofetil for prevention of acute myocardial rejection is dependent on routine monitoring of mycophenolic acid through acid levels
16. Myasthenia gravis: Long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity
17. Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines
18. Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells
19. Single-center analysis of the incidence of acute rejection in cadaveric renal allograft recipients induced with low-dose OKT3 with and without mycophenolate mofetil
20. Intestinal microsporidiosis occurring in two renal transplant recipients treated with mycophenolate mofetil
21. Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil